Published in Invest Ophthalmol Vis Sci on September 01, 2005
Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. Annu Rev Pharmacol Toxicol (2007) 3.86
Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest Ophthalmol Vis Sci (2008) 1.96
An update on the genetics of age-related macular degeneration. Mol Vis (2007) 1.95
Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.92
Interpretations of fundus autofluorescence from studies of the bisretinoids of the retina. Invest Ophthalmol Vis Sci (2010) 1.75
Retinoids for treatment of retinal diseases. Trends Pharmacol Sci (2010) 1.18
Ocular fundus auto-fluorescence observations at different wavelengths in patients with age-related macular degeneration and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2007) 1.14
Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area. Retina (2012) 1.07
Time-resolved autofluorescence imaging of human donor retina tissue from donors with significant extramacular drusen. Invest Ophthalmol Vis Sci (2012) 1.04
Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol (2007) 1.03
Macular autofluorescence in eyes with cystoid macula edema, detected with 488 nm-excitation but not with 580 nm-excitation. Graefes Arch Clin Exp Ophthalmol (2009) 1.03
Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept. Clin Ophthalmol (2012) 0.97
Semi-automatic geographic atrophy segmentation for SD-OCT images. Biomed Opt Express (2013) 0.97
[Comparison of parameters of time-resolved autofluorescence between healthy subjects and patients suffering from early AMD]. Ophthalmologe (2009) 0.97
Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration. Invest Ophthalmol Vis Sci (2014) 0.95
Fundus autofluorescence and optical coherence tomography findings in choroidal melanocytic lesions. Middle East Afr J Ophthalmol (2010) 0.95
Anatomic alterations in aging and age-related diseases of the eye. Invest Ophthalmol Vis Sci (2013) 0.94
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). Invest Ophthalmol Vis Sci (2013) 0.94
Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. Am J Ophthalmol (2009) 0.93
Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects. Clin Ophthalmol (2015) 0.91
Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen. Ophthalmology (2015) 0.90
Interactive segmentation for geographic atrophy in retinal fundus images. Conf Rec Asilomar Conf Signals Syst Comput (2008) 0.90
Multimodal instrument for high-sensitivity autofluorescence and spectral optical coherence tomography of the human eye fundus. Biomed Opt Express (2013) 0.88
Fundus autofluorescence in exudative age-related macular degeneration. Br J Ophthalmol (2006) 0.86
Fundus Autofluorescence and RPE Lipofuscin in Age-Related Macular Degeneration. J Clin Med (2014) 0.85
Fundus autofluorescence imaging: Fundamentals and clinical relevance. Saudi J Ophthalmol (2014) 0.85
Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2015) 0.84
Foveal RPE autofluorescence as a prognostic factor for anti-VEGF therapy in exudative AMD. Graefes Arch Clin Exp Ophthalmol (2008) 0.83
Retinal flavoprotein autofluorescence as a measure of retinal health. Trans Am Ophthalmol Soc (2008) 0.83
Characteristics of fundus autofluorescence and drusen in the fellow eyes of Japanese patients with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2013) 0.80
Fundus autofluorescence of choroidal melanocytic lesions and the effect of treatment. Trans Am Ophthalmol Soc (2007) 0.80
Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration. Clin Ophthalmol (2016) 0.80
Macular pigment density at the site of altered fundus autofluorescence. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
Fundus autofluorescence imaging in dry AMD: 2014 Jules Gonin lecture of the Retina Research Foundation. Graefes Arch Clin Exp Ophthalmol (2014) 0.79
Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature. Biomed Res Int (2015) 0.79
Clinical applications of fundus autofluorescence in retinal disease. Int J Retina Vitreous (2016) 0.78
In-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imaging. Graefes Arch Clin Exp Ophthalmol (2015) 0.78
Formation and growth of lipofuscin in the retinal pigment epithelium cells. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 0.77
Combined grading for choroidal neovascularisation: colour, fluorescein angiography and autofluorescence images. Graefes Arch Clin Exp Ophthalmol (2007) 0.77
Intrinsic tissue fluorescence in an organotypic perfusion culture of the porcine ocular fundus exposed to blue light and free radicals. Graefes Arch Clin Exp Ophthalmol (2008) 0.77
Restricted Summed-Area Projection for Geographic Atrophy Visualization in SD-OCT Images. Transl Vis Sci Technol (2015) 0.77
Photic injury to cultured RPE varies among individual cells in proportion to their endogenous lipofuscin content as modulated by their melanosome content. Invest Ophthalmol Vis Sci (2014) 0.76
The 2014 Bowman Lecture-Bowman's and Bruch's: a tale of two membranes during the laser revolution. Eye (Lond) (2015) 0.75
AMD-like retinopathy associated with intravenous iron. Exp Eye Res (2016) 0.75
Evaluation of fundus autofluorescence patterns in age-related macular degeneration. Int J Ophthalmol (2016) 0.75
CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina (2016) 0.75
Fundus autofluorescence in chronic essential hypertension. J Ophthalmic Vis Res (2015) 0.75
Fundus Autofluorescence in Age-related Macular Degeneration. Optom Vis Sci (2016) 0.75
Fundus autofluorescence applications in retinal imaging. Indian J Ophthalmol (2015) 0.75
Spotlight on reticular pseudodrusen. Clin Ophthalmol (2017) 0.75
Subfoveal choroidal neovascularization in a patient with hemicentral vein occlusion. Int Ophthalmol (2009) 0.75
Ultra-widefield fundus autofluorescence in age-related macular degeneration. PLoS One (2017) 0.75
Fundus autofluorescence and fate of glycoxidized particles injected into subretinal space in rabbit age-related macular degeneration model. Graefes Arch Clin Exp Ophthalmol (2009) 0.75
Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47
Age-related macular degeneration. Lancet (2012) 4.17
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Fundus autofluorescence imaging: review and perspectives. Retina (2008) 3.22
Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci (2009) 3.19
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol (2007) 3.00
Dry powder inhalers: which factors determine the frequency of handling errors? Respiration (2007) 2.81
Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol (2006) 2.80
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol (2008) 2.52
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study. Ophthalmology (2011) 2.47
Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol (2013) 2.44
Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa. Hum Mol Genet (2002) 2.34
Systemic complement activation in age-related macular degeneration. PLoS One (2008) 2.18
Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am J Ophthalmol (2002) 2.09
The "diffuse-trickling" fundus autofluorescence phenotype in geographic atrophy. Invest Ophthalmol Vis Sci (2014) 2.06
Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology (2007) 2.03
Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am J Ophthalmol (2004) 2.03
High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 2.03
Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci (2005) 2.02
An update on the genetics of age-related macular degeneration. Mol Vis (2007) 1.95
Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol (2005) 1.95
Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol (2007) 1.94
Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell (2007) 1.93
Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol (2009) 1.92
Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A (2004) 1.90
Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance? Invest Ophthalmol Vis Sci (2003) 1.85
The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci (2009) 1.84
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology (2011) 1.79
High concentration of zinc in sub-retinal pigment epithelial deposits. Exp Eye Res (2007) 1.78
Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A (2007) 1.77
Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology (2002) 1.74
Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol (2006) 1.72
Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol (2010) 1.71
Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.70
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations. Retina (2015) 1.67
Mineral trioxide aggregate or calcium hydroxide direct pulp capping: an analysis of the clinical treatment outcome. J Endod (2010) 1.67
Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol (2004) 1.64
Genetic influence on early age-related maculopathy: a twin study. Ophthalmology (2002) 1.57
Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology (2005) 1.57
Differential targeting of GSH1 and GSH2 is achieved by multiple transcription initiation: implications for the compartmentation of glutathione biosynthesis in the Brassicaceae. Plant J (2005) 1.57
Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update. Doc Ophthalmol (2007) 1.56
Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci (2006) 1.56
Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: a prospective study. Ophthalmology (2007) 1.51
Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxanthin: new results from the LUNA study. Invest Ophthalmol Vis Sci (2012) 1.51
Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. Am J Ophthalmol (2006) 1.50
Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol (2009) 1.46
Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Invest Ophthalmol Vis Sci (2014) 1.46
A link between impaired lung function and increased cardiac stress. Respiration (2009) 1.45
Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci (2004) 1.45
NT-proBNP for pulmonologists: not only a rule-out test for systolic heart failure but also a global marker of heart disease. Respiration (2009) 1.45
Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography. Acta Ophthalmol (2010) 1.44
Macular telangiectasia type 2. Prog Retin Eye Res (2012) 1.44
Phenotypic variation in enhanced S-cone syndrome. Invest Ophthalmol Vis Sci (2008) 1.43
Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci (2008) 1.42
Decompression illness reported in a survey of 429 recreational divers. Aviat Space Environ Med (2008) 1.41
The prevalence of type 2 idiopathic macular telangiectasia in two African populations. Ophthalmic Epidemiol (2012) 1.41
Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention (2014) 1.41
Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One (2013) 1.40
In vivo safety of trypan blue use in vitreoretinal surgery. Retina (2011) 1.40
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med (2017) 1.40
Impact of enhanced resolution, speed and penetration on three-dimensional retinal optical coherence tomography. Opt Express (2009) 1.39
Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology (2010) 1.38
Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany. Acta Ophthalmol (2012) 1.38
A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease. Mol Vis (2006) 1.38
Intraocular pharmacokinetics after a single intravitreal injection of 1.5 mg versus 3.0 mg of bevacizumab in humans. Retina (2011) 1.37
Incidence of blindness and severe visual impairment in Germany: projections for 2030. Invest Ophthalmol Vis Sci (2011) 1.36
Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol (2011) 1.36
Reticular drusen associated with geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.34
Advances in our understanding of diabetic retinopathy. Clin Sci (Lond) (2013) 1.34
The role of the complement system in age-related macular degeneration. Dtsch Arztebl Int (2014) 1.34
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One (2009) 1.34
Novel phenotypic and genotypic findings in X-linked retinoschisis. Arch Ophthalmol (2007) 1.34
Elaborate spatial patterning of cell-wall PME and PMEI at the pollen tube tip involves PMEI endocytosis, and reflects the distribution of esterified and de-esterified pectins. Plant J (2007) 1.34
Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci (2006) 1.34
Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study. Ophthalmology (2013) 1.33
Structural insights into the target specificity of plant invertase and pectin methylesterase inhibitory proteins. Plant Cell (2004) 1.33
Artifacts in automatic retinal segmentation using different optical coherence tomography instruments. Retina (2010) 1.32
Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans. Am J Ophthalmol (2012) 1.32
Spectral-domain OCT evaluation of Nd:YAG laser treatment for Valsalva retinopathy. Graefes Arch Clin Exp Ophthalmol (2009) 1.31
Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.31
Comparison of fundus autofluorescence with photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci (2004) 1.30